Summary
Calcium antagonists have been reported to decrease the incidence of sudden death in postinfarction management and vulnerability to fibrillation secondary to experimental coronary occlusion. In order to confirm such beneficial results regarding ischaemic ventricular fibrillation, the threshold intensity for fibrillation electrically induced with impulses of 100 ms and 180 beats · min−1 was measured during the course of ischaemias obtained by total occlusion of the left anterior descending coronary artery near its origin in open-chest pigs. The variations of electrical fibrillation threshold with ischaemia duration (30, 60, 120, 180, 240, 360 s) were compared under control conditions and after i.v. diltiazem (0.50 mg · kg−1 plus 0.02 mg · kg−1 · min−1 over 25 min). Electrical fibrillation threshold was not influenced by diltiazem before, but raised during ischaemia, particularly from the 60th s (1.7 to 4.0 mA), with delay in the triggering of fibrillation which occurs when the fibrillation threshold falls down to the pacing threshold (0.2 to 0.3 mA). In 6 pigs out of 8, fibrillation was even avoided in the longest of the ischaemic periods considered (360 s), for fibrillation threshold ceased falling before reaching the critical level. These experimental results obtained with diltiazem are consistent with the clinical effectiveness of calcium antagonists recently observed in the prevention of postinfarction sudden death, provided that myocardial contractility is not too much adversely affected. But, left ventricular dP/dtmax was not reduced by more than 6.8% in the present experiments.
Similar content being viewed by others
References
Antman EM, Berlin JA (1992) Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine. Circulation 86:764–773
Aupetit IF, Chevrel G, Omar S, Loufoua J, Timour Q, Faucon G (1993 a) Absence of protection by lidocaine against ischaemic fibrillation: enhanced fall of electrical threshold for fibrillation. Fund Clin Pharmacol 7:191 (abstract)
Aupetit JF, Timour Q, Chevrel G, Omar S, Loufoua-Moundanga J, Faucon G (1993b) Influence comparée des diverses classes d'antiarythmiques sur la vulnérabilité à la fibrillation ventriculaire ischémique. Arch Mal Coeur (in press)
Aupetit JF, Timour Q, Larbre JP, Loufoua-Moundanga J, Kioueh I, Lopez M, Faucon G (1993c) Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischaemia. Study in the porcine in situ heart. Cardiovasc Drugs Ther 7:217–223
Bergey JL, Wendt RL, Nocella K, McCallum JD (1984) Acute coronary artery occlusion-reperfusion arrhythmias in pigs. Antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. Eur J Pharmacol 97:95–103
Brooks WW, Verrier RL, Lown B (1980) Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion. Cardiovasc Res 14:295–302
Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406–412
Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1991) Mortality and morbidity in patients receiving encainide, flecainide or placebo. N Engl J Med 324:781–788
Clusin WT, Bristow MR, Karagueuzian HS, Katzung BG, Schroeder JS (1982) Do calcium-dependent ionic currents mediate ventricular fibrillation? Am J Cardiol 49:606–612
Clusin WT, Buchbinder M, Ellis AK, Kernoff RS, Giacomini JC, Harrison DC (1984) Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Circ Res 54:10–20
Cranefield PF (1977) Action potentials, afterpotentials and arrhythmias Circ Res 41:15–23
Danish Verapamil Infarction Trial II (DAVIT II) (1990) Effect of verapamil on mortality and major events after acute myocardial infarction. Am J Cardiol 66:779–785
Downar E, Janse MJ, Durrer D (1977) The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart. Circulation 56:217–224
Elharrar V, Guam WE, Zipes DP (1977) Effects of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Am J Cardiol 39:544–549
Farges JP, Faucon G, Lièvre M, Ollagnier M (1978) Relationship between atrial and ventricular rates of fibrillation and cardiac contractile tissue refractory periods in the dog. Br J Pharmacol 63:587–591
Fondacaro JD, Han J, Yoon MS (1978) Effects of verapamil on ventricular rhythm during acute coronary occlusion. Am Heart J 96:81–86
Friedrich R, Hirche H, Kebbel U, Zylka V, Bissig R (1981) Changes of extracellular Na+, K+, Ca2+ and H+ in the ischemic myocardium in pigs. Basic Res Cardiol 76:453–456
Gettes LS, Cascio WE, Johnson T, Fleet WF (1991) Local myocardial biochemical and ionic alterations during myocardial ischaemia and reperfusion. Drugs 42 [Suppl 1]:7–13
Hagar JM, Hale SL, Kloner RA (1991) Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res 68:61–68
ISIS-1 Collaborative Group (1986) Randomized trial of intravenous atenolol among 16027 cases of suspected myocardial infarction. Lancet II:57–60
Kaumann AJ, Aramendia P (1968) Prevention of ventricular fibrillation induced by coronary ligation. J Pharmacol Exp Ther 164:326–332
Kimura S, Bassett A, Kohya T, Kozlovskis PL, Myerburg RJ (1987) Regional effects of verapamil on recovery of excitability and conduction time in experimental ischemia. Circulation 76:1146–1154
Kjekshus JK (1986) Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57:43F-49F
Lang J, Timour Q, Charve P, Aupetit JF, El Chebly M, Faucon G (1987) Role of calcium in the rate-dependent depression of atrioventricular nodal conduction in the dog heart under vagal influence. Int J Cardiol 15:65–76
Loufoua J, Omar S, Chevrel G, Aupetit JF, Timour Q, Faucon G (1993) Aggravation by Ic antiarrhythmic drugs of the gradual decrease of electrical threshold for fibrillation produced by ischaemia. Fund Clin Pharmacol 7:188 (abstract)
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136
Nayler WG, Panagiotopoulos S, Elz JS, Sturrock WJ (1987) Fundamental mechanisms of action of calcium antagonists in myocardial ischemia. Am J Cardiol 59:7513–8313
Persson S (1991) Calcium antagonists in secondary prevention after myocardial infarction. Drugs 42 [Suppl 2]:54–60
Peter T, Fujimoto T, Hamamoto H, Mandel WJ (1983) Comparative study of the effect of slow channel inhibiting agents on ischemia-induced conduction delay as relevant to the genesis of ventricular fibrillation. Am Heart J 106:1023–1028
Rafflenbeul W, Ebner F (1991) Myocardial infarction. Secondary prevention with nifedipine. Drugs 42 [Suppl 2]:38–42
Rehnqvist N. Prevention of sudden death by beta-blockers (1990) Cardiovasc Drugs Ther 4:675–680
Singh BN (1989) Advantages of beta-blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction. Am J Cardiol 66:9C-20C
Singh BN (1992) Routine lidocaine administration in acute myocardial infarction. An idea whose time is all but gone? Circulation 86:1033–1035
Surawicz B (1982) Role of calcium-blocking agents in treatment of cardiac arrhythmias related to myocardial ischemia. Am Heart J 103:698–706
Steenbergen C, Murphy E, Levy L, London RE (1987) Elevation in cytosolic free calcium concentration early in myocardial ischaemia in perfused rat heart. Circ Res 60:700–707
Tan HL, Mazon P, Verberne HJ, Sleeswijk ME, Coronel R, Opthof T, Janse MJ (1993) Ischaemic preconditioning delays ischaemia-induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. Circ Res 27:644–651
Tani M (1990) Mechanisms of Ca2+ overload in reperfused ischemic myocardium. Annu Rev Physiol 52:543–559
Timour Q, Bertrix L, Bouzouita K, Lang J, Faucon G (1983) Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ. Arch Int Pharmacodyn 261:238–247
Timour Q, Aupetit JF, Loufoua-Moundanga J, Gerentes-Chassagne I, Kioueh I, Faucon G (1991a) Class Ic antiarrhythmic drugs and myocardial ischaemia. Study in the pig in situ heart. Naunyn-Schmiedeberg's Arch Pharmacol 343:645–651
Timour Q, Larbre JP, Aupetit JF, Gerentes-Chassagne I, Loufoua-Moundanga J, Kioueh I, Faucon G (1991b) Protection against ischaemic ventricular fibrillation by blocking agents of myocardial cell calcium influx. Electrophysiological study in the pig in situ heart. Fund Clin Pharmacol 5:641–644
Timour Q, Aupetit JF, Loufoua-Moundanga J, Kioueh I, Omar S, Chevrel G, Faucon G (1992a) Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs. Fund Clin Pharmacol 6:159–167
Timour Q, Aupetit JF, Loufoua J, Omar S, Bertrix L, Faucon G (1992 b) Heart rate and vulnerability to fibrillation in the acutely ischaemic myocardium. Fund Clin Pharmacol 6:214 (abstract)
Timour Q, Larbre JP, Kioueh I, Aupetit JF, Loufoua-Moundanga J, Vialle A, Faucon G (1992c) Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation. Modification of cellular calcium overload. Arch Int Pharmacodyn 315:30–46
Vegh A, Komori S, Szekeres L, Parratt JR (1992) Antiarrhythmic effects of preconditoning in anaesthetised dogs and rats. Cardiovasc Res 26:487–495
Wiegand V, Guggi M, Meesmann W, Kessler H, Greitschus F (1979) Extracellular potassium activity changes in the canine myocardium after coronary artery occlusion and the influence of beta-blockade. Cardiovasc Res 13:297–302
Wilde AAM, Kleber AG (1986) The combined effects of hypoxia, high K+ and acidosis on the intracellular sodium activity and resting potential in guinea-pig papillary muscle. Circ Res 58:249–256
Author information
Authors and Affiliations
Additional information
Correspondence to: Q. Timour at the above address
Rights and permissions
About this article
Cite this article
Aupetit, J.F., Timour, Q., Chevrel, G. et al. Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem. Naunyn-Schmiedeberg's Arch Pharmacol 348, 509–514 (1993). https://doi.org/10.1007/BF00173211
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173211